Skip to main content

Home/ Dr. Goodyear/ Group items matching "octreotide" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
1More

Long-Acting Octreotide for the Treatment and Symptomatic Relief of Bowel Obstruction in... - 0 views

www.sciencedirect.com/...S0885392405005397 octreotide cancer
shared by Nathan Goodyear on 11 Sep 13 - No Cached
  • Nathan Goodyear on 11 Sep 13
     
    Long term octreotide well tolerated in patients with recurrent ovarian cancer.  
1More

The role of octreotide and somatostatin in acute a... [Digestion. 1999] - PubMed - NCBI - 0 views

www.ncbi.nlm.nih.gov/...10207228 octreotide pancreatitis
shared by Nathan Goodyear on 11 Sep 13 - No Cached
  • Nathan Goodyear on 11 Sep 13
     
    Octreotide useful in pancreatitis.
1More

A phase II study of high-dose octreotide in patients with unresectable pancreatic carci... - 0 views

www.sciencedirect.com/...S095980499900177X octreotide cancer pancreatic
shared by Nathan Goodyear on 11 Sep 13 - No Cached
  • Nathan Goodyear on 11 Sep 13
     
    Octreotide shown to be of some benefit in those with stage II to IV pancreatic cancer.  The number of individuals positively impacted was small (19%) for 12 weeks, but another tool in the battle against cancer.
1More

Long‐acting octreotide versus placebo for treatment of advanced HCC: A random... - 0 views

aasldpubs.onlinelibrary.wiley.com/...hep.21468 octreotide GH growth hormone cancer liver cancer
shared by Nathan Goodyear on 09 Jul 18 - No Cached
  • Nathan Goodyear on 09 Jul 18
     
    Octreotide, GH inhibitor, no better than placebo in liver cancer.
1More

Octreotide - A Review of its Use in Treating Neuroendocrine Tumours - PMC - 0 views

www.ncbi.nlm.nih.gov/...PMC5983100 neuroendocrine tumors octreotide
shared by Nathan Goodyear on 15 Dec 22 - No Cached
  • Nathan Goodyear on 15 Dec 22
     
    Octreotide prolongs time interval to tumor progression in neuroendocrine tumors.
1More

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant:... - 0 views

clincancerres.aacrjournals.org/...1000 cancer GH growth hormone
shared by Nathan Goodyear on 12 Aug 19 - No Cached
  • Nathan Goodyear on 12 Aug 19
     
    Pegvisomant shown to provide more GH, IGF-1 suppression compared to octreotide. The doses used were 40, 60, and 80 mg SQ. The higher dose resulted in the greatest suppression.
1More

Management of Bleeding in Patients with Advanced Cancer - 0 views

theoncologist.alphamedpress.org/...561.long cancer bleeding octreotide
shared by Nathan Goodyear on 24 Aug 18 - No Cached
  • Nathan Goodyear on 24 Aug 18
     
    therapies to try and control GI bleeding.
1 - 9 of 9
Showing 20▼ items per page